HomeFERMENTA › Filing
🔔 Get instant alerts when FERMENTA files quarterly results on BSE Start free trial →

Earnings presentation - Q1/FY27

Filed: 11 Aug 2026, 13:47 IST Exchange: BSE Category: Financial Results — Investor Presentation
Investor Presentation - Q1FY27 - Revenue INR 126.2 crore, down 13% YoY, flat QoQ; EBITDA INR 22.4 crore, down 39% YoY, down 11% QoQ; PAT INR 9.5 crore, down 56% YoY, down 49% QoQ - Human nutrition revenue up 24% QoQ to INR 76.5 crore; India revenue share rose to 47% from 35% YoY - Other APIs and Intermediates up 18% YoY; Green Chemistry Solutions up 15% YoY; Animal nutrition volumes down 52% QoQ - Cost improvements with raw materials at 35% of revenue vs 37% in FY26; employee costs higher at 19% due to capacity expansion - Strategic focus on innovation chemistry, plant-source Vitamin D3, and expanding global leadership - Post-quarter milestones: FSSAI approval for VITADEE Green and 7th place in India’s Great Mid-size Workplaces 2026
Source: Original filing PDF — view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts BOT
🚨 FERMENTA — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
✓✓ 6:47 PM
🎧
Instant audio summaries2-min AI concall recap delivered with every earnings alert
📊
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
🔍
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes

Add FERMENTA to your watchlist — all of this, automated.

Sign in with Google
14-day Pro trial · No credit card · Cancel anytime

More on Fermenta Biotech Limited

Important. The summary above is generated automatically from Fermenta Biotech Limited's own public regulatory filing under SEBI LODR. Indian Stock Alerts is not a SEBI-registered Research Analyst or Investment Adviser. This page is informational, not investment advice, a recommendation to buy or sell any security, or any opinion about the company's business, governance or financial health. Always read the original filing before acting and consult a registered adviser for investment decisions.